Lipoprotein(a) and apo(a) phenotypes are associated with carotid atherosclerosis in younger coronary heart disease patients

被引：0
|
作者：
Afanasieva, O. I. [1 ]
Ezhov, M. V. [1 ]
Lyakishev, A. A. [1 ]
Afanasieva, M. I. [1 ]
Kukharchuk, V. V. [1 ]
Pokrovsky, S. N. [1 ]
机构：
[1] Cardiol Res Ctr, Moscow 121552, Russia
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(07)71081-4
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [1] Lipoprotein (a), coronary heart disease, and carotid artery atherosclerosis in the Framingham heart study.
    Schaefer, EJ
    Ordovas, JM
    DeLuca, C
    DAgostino, RB
    Wolf, PA
    TaddeiPeters, W
    Butman, RJ
    Silberman, SR
    Wilson, PWF
    [J]. CLINICAL CHEMISTRY, 1997, 43 : 747 - 747
  • [2] Relation of lipoprotein Lp(a) concentration and apolipoprotein apo(a) phenotypes to the presence and severity of carotid atherosclerosis
    Afanasieva, OI
    Ezhov, MV
    Benevolenskaya, GF
    Balakhonova, TV
    Lyakishev, AA
    Pokrovsky, SN
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 136 - 136
  • [3] Association of lipoprotein(a) and apolipoprotein(a) phenotypes with coronary and carotid atherosclerosis in CHD men
    Ezhov, MV
    Afanasyeva, OI
    Benevolenskaya, GF
    Savchenko, AP
    Balakhonova, TV
    Lyakishev, AA
    Pokrovsky, SN
    [J]. TERAPEVTICHESKII ARKHIV, 2000, 72 (01): : 28 - 32
  • [4] Extracorporeal lipoprotein(a) elimination for coronary atherosclerosis regression in coronary heart disease patients with elevated lipoprotein(a) levels
    Safarova, M. S.
    Matchin, Y. U. G.
    Ezhov, M. V.
    Khaustov, A. I.
    Afanasieva, M. I.
    Atanesyan, R. V.
    Utkina, E. A.
    Konovalov, G. A.
    Pokrovsky, S. N.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 447 - 448
  • [5] Carotid atherosclerosis detectability in patients with coronary heart disease and arterial hypertension
    Astanina, IA
    Dudko, VA
    Vorozhtsova, IN
    [J]. TERAPEVTICHESKII ARKHIV, 2004, 76 (12): : 36 - 39
  • [6] Lipoprotein (a), Apo (a) phenotypes and dyslipidemia in acute coronary syndromes
    Rohbani-Noubar, M
    Zarghami, N
    Rashtchizadeh, N
    [J]. CLINICA CHIMICA ACTA, 2005, 355 : S102 - S103
  • [7] Lipoprotein (a), Apo(a) phenotypes and dyslipidemia in acute coronary syndromes
    不详
    [J]. CLINICAL BIOCHEMISTRY, 2005, 38 (09) : 860 - 860
  • [8] THE ROLE OF LIPOPROTEIN(A) AND APOLIPOPROTEIN(A) PHENOTYPES IN SEVERE ATHEROSCLEROSIS OF CORONARY, CAROTID AND LOWER LIMBS ARTERIES
    Tmoyan, N.
    Ezhov, M.
    Afanasieva, O.
    Klesareva, E.
    Pogorelova, O.
    Tripoten, M.
    Afanasieva, M.
    Razova, O.
    Pokrovsky, S.
    [J]. ATHEROSCLEROSIS, 2018, 275 : E162 - E162
  • [9] LIPOPROTEIN(A) AS A BIOMARKER FOR SUBCLINICAL CORONARY AND CAROTID ATHEROSCLEROSIS IN ASYMPTOMATIC PATIENTS
    Low, B.
    Trivedi, N.
    Loh, W. J.
    David, A.
    Cegla, J.
    [J]. ATHEROSCLEROSIS, 2021, 331 : E113 - E114
  • [10] Management of patients with associated coronary and carotid atherosclerosis
    Surkova, Elena
    Shchukin, Yuri
    Vachev, Alexey
    Germanov, Andrey
    Tereshina, Olga
    [J]. CIRCULATION, 2012, 125 (19) : E794 - E794
12345